Guy’s & St Thomas’ Hospitals, and King’s College London

David Jackson is Professor of Respiratory Medicine at King’s College London and Head of the regional Severe Asthma and Eosinophilic Lung Disease Service based at Guy’s Hospital in London. This unit is one of the largest of its kind in the world with over 1000 patients on biologic therapies for severe asthma and EGPA.

Professor Jackson has an MSc in Allergy and PhD in the pathophysiology of virus-induced asthma exacerbations from Imperial College London. He has published widely in the field of type 2 immunity, asthma and eosinophil associated diseases including in NEJM, Lancet and Nature Medicine. He co-edited the European Respiratory Society Monograph on Eosinophilic Lung Diseases and is the Associate Editor at the journals THORAX and ALLERGY.

He has been the Chief Investigator on multiple phase 3 and 4 clinical trials in asthma and is chair of the Specialist Advisory Group on asthma for the British Thoracic Society.